Trademarkia Logo

Australia

AU$
REBLOZYL
Protected: Registered/protected

Last updated on 14 Nov 2024

Owner Info

Celgene Corporation

Route 206 & Province Line Road

Princeton NJ 08543, UNITED STATES OF AMERICA

Serial Number

1843749 filed on 14 Feb 2017

Correspondent

KIRKPATRICK, SA/NV

Avenue Wolfers 32,

B-1310 La Hulpe,

BELGIUM

REBLOZYL

Classification Information


Class [005]
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, bl Read More

Mark Details


Serial Number

1843749

Registered On

14 Feb 2017

Renewal On

14 Feb 2027

Mark Type

WORD

Priority Claim (Convention Details)


Date

9 Feb 2017

Mark Type

US

Legal History


Show more

Status DateAction Taken
14th Nov 2024Amendment to Amend Owner Requested
7th Sept 2023Amendment to International Registration Contact Requested
6th May 2021Amendment to International Registration Contact Requested
14th Sept 2017IP Right Registration Published
6th Sept 2017Application Status
6th Sept 2017Register Trade Mark
29th Jun 2017IP Right Acceptance Published
23rd Jun 2017Amend Status from Awaiting Advertisement
29th May 2017Application Accepted correspondence sent
29th May 2017Clear Examination report approved